Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,134 recalls, newest first

Class III · Low risk

Famotidine tablets

Failed impurities/degradation specifications: Famotodine has an out of specification result for an individual related substance observed during routine stability testing of a batch for related substances -impurity 8 at 24 month stability interval.

Terminated Impurity / degradation Dr. Reddy's Laboratories, Inc. NDC 55111-118-30 D-0009-2018
Class II · Moderate risk

Bisoprolol Fumarate tablets

Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was observed during the 18 month stability testing.

Terminated Impurity / degradation Unichem Pharmaceuticals Usa Inc NDC 29300-126-13 D-0010-2018
Class II · Moderate risk

Lorazepam Tablets

Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam

Terminated Labeling / mix-up Leading Pharma, LLC NDC 69315-904-05 D-0085-2018
Class II · Moderate risk

Glutamine

CGMP Deviations; FDA analysis deterrmined that the product does not contain glutamine and two unknown impurities were observed

Terminated Impurity / degradation United Pharmacy D-0008-2018
Class II · Moderate risk

Alprazolam Tablets

Failed Impurities/Degradation Specifications: Out-of-specification result for an unknown impurity.

Terminated Impurity / degradation The Harvard Drug Group NDC 0904-5858-61 D-0013-2018
Class III · Low risk

Ampicillin for Injection

Labeling: Missing Label: customer complaint that some vials of ampicillin within the shrink wrap pack are missing labels.

Terminated Labeling / mix-up Sandoz Inc NDC 0781-3407-78 D-1179-2017
Class II · Moderate risk

methylPREDNIsolone ACETATE

Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.

Terminated Sterility / contamination RXQ Compounding LLC D-0012-2018
Class III · Low risk

Mobic (meloxicam)

Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.

Terminated Labeling / mix-up Boehringer Ingelheim Pharmaceuticals, Inc. NDC 0597-0030-01 D-0007-2018
Class II · Moderate risk

Medline Skin Stapler RMVR

Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.

Terminated Wrong potency / content Medline Industries Inc D-0314-2018

Recalls by year